Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone

Free Abstracts


  Free Subscription


1 Am J Clin Pathol
2 Am J Hematol
2 Ann Hematol
1 Exp Hematol
1 J Natl Cancer Inst
5 Leuk Lymphoma

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles

    Am J Clin Pathol

  1. AMATO T, Sall A, Dieye TN, Gozzetti A, et al
    Preferential Usage of Specific Immunoglobulin Heavy Chain Variable Region Genes With Unmutated Profile and Advanced Stage at Presentation Are Common Features in Patients With Chronic Lymphocytic Leukemia From Senegal.
    Am J Clin Pathol. 2017;148:545-554.
    PubMed     Text format     Abstract available

    Am J Hematol

  2. GODET S, Protin C, Dupuis J, Dartigeas C, et al
    Outcome of chronic lymphocytic leukemia patients who switched from either ibrutinib or idelalisib to alternate kinase inhibitor: A retrospective study of the French Innovative Leukemia Organization (FILO).
    Am J Hematol. 2017 Nov 22. doi: 10.1002/ajh.24981.
    PubMed     Text format    

  3. WALTER RB, Michaelis LC, Othus M, Uy GL, et al
    Intergroup LEAP Trial (S1612): A Randomized Phase 2/3 Platform Trial to Test Novel Therapeutics in Medically Less Fit Older Adults with Acute Myeloid Leukemia.
    Am J Hematol. 2017 Nov 22. doi: 10.1002/ajh.24980.
    PubMed     Text format    

    Ann Hematol

  4. HASSANI S, Khaleghian A, Ahmadian S, Alizadeh S, et al
    Redistribution of cell cycle by arsenic trioxide is associated with demethylation and expression changes of cell cycle related genes in acute promyelocytic leukemia cell line (NB4).
    Ann Hematol. 2017 Nov 20. doi: 10.1007/s00277-017-3163.
    PubMed     Text format     Abstract available

  5. PRATS-MARTIN C, Jimenez-Guerrero P, Morales-Camacho RM, Caballero-Velazquez T, et al
    KIT D816V- chronic myelomonocytic leukemia progressing to KIT D816V+ associated to mast cell leukemia responding to allogeneic hematopoietic cell transplantation.
    Ann Hematol. 2017 Nov 18. doi: 10.1007/s00277-017-3187.
    PubMed     Text format    

    Exp Hematol

  6. CASTAGNA L, Devillier R, Vey N, Blaise D, et al
    T cell replete-haploidentical transplantation in acute myeloid leukemia.
    Exp Hematol. 2017 Nov 16. pii: S0301-472X(17)30861.
    PubMed     Text format     Abstract available

    J Natl Cancer Inst

  7. MITCHELL R, Hopcroft LEM, Baquero P, Allan EK, et al
    Targeting BCR-ABL-Independent TKI Resistance in Chronic Myeloid Leukemia by mTOR and Autophagy Inhibition.
    J Natl Cancer Inst. 2017 Nov 20. doi: 10.1093.
    PubMed     Text format     Abstract available

    Leuk Lymphoma

  8. RIBERA JM, Morgades M, Montesinos P, Martino R, et al
    Efficacy and safety of native versus pegylated Escherichia coli asparaginase for treatment of adults with high-risk, Philadelphia chromosome-negative acute lymphoblastic leukemia.
    Leuk Lymphoma. 2017 Nov 22:1-10. doi: 10.1080/10428194.2017.1397661.
    PubMed     Text format     Abstract available

  9. KANNA R, Choudhary G, Ramachandra N, Steidl U, et al
    STAT3 inhibition as a therapeutic strategy for leukemia.
    Leuk Lymphoma. 2017 Nov 22:1-7. doi: 10.1080/10428194.2017.1397668.
    PubMed     Text format     Abstract available

  10. PEI R, Si T, Lu Y, Zhou JX, et al
    Salvianolic acid A, a novel PI3K/Akt inhibitor, induces cell apoptosis and suppresses tumor growth in acute myeloid leukemia.
    Leuk Lymphoma. 2017 Nov 22:1-9. doi: 10.1080/10428194.2017.1399314.
    PubMed     Text format     Abstract available

  11. GOHIL SH, Maciocia N, Patrick P, Roberts T, et al
    LenD: a study to establish the safety and efficacy of lenalidomide and dexamethasone in patients with relapsed or refractory chronic lymphocytic leukemia.
    Leuk Lymphoma. 2017 Nov 22:1-4. doi: 10.1080/10428194.2017.1399311.
    PubMed     Text format    

    The importance of FLT3 mutational analysis in acute myeloid leukemia.
    Leuk Lymphoma. 2017 Nov 22:1-14. doi: 10.1080/10428194.2017.1399312.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Leukemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.